Differentiation of pulmonary cytokines and purinergic molecules with potential prognostic value and immunomodulatory properties in non-small cell lung cancer patients
- Conditions
- C34Malignant neoplasm of bronchus and lung
- Registration Number
- DRKS00005415
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Patients with suspected or proven non-small-cell lung cancer
Exclusion Criteria
Other malignant disease, other lung disease like asthma, sarcoidosis, fibrosis (not COPD), acute systemic or pulmonary infection, patients undergoing chemotherapie, immunosuppressive therapy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurement of ATP directly after sample acquisition. <br>Measurement of cytokines via ELISA and RNA via qPCR after completion of patient recruitment.
- Secondary Outcome Measures
Name Time Method